Management of Atrial Fibrillation with Hypotension in the ICU

Immediate Stabilization

The American College of Cardiology recommends performing immediate electrical cardioversion without delay in ICU patients with atrial fibrillation and hypotension, as hemodynamic instability mandates urgent rhythm restoration rather than pharmacological rate control 1, 2
Electrical cardioversion is the definitive treatment for AF with hemodynamic compromise and should not be delayed for anticoagulation, according to the American College of Cardiology 1, 2, 3
Administer synchronized electrical cardioversion immediately when hypotension, shock, acute heart failure, or myocardial ischemia is present, as recommended by the American College of Cardiology 1, 2
Concurrently initiate intravenous heparin (if not contraindicated) with an initial bolus followed by continuous infusion targeting aPTT 1.5-2 times control, as suggested by the American College of Cardiology 1, 2
After successful cardioversion, continue oral anticoagulation with target INR 2-3 for at least 3-4 weeks, according to the American College of Cardiology 1, 2

The American College of Cardiology recommends intravenous amiodarone as the preferred agent for rate control in hypotensive ICU patients with AF, as it provides both rate control and rhythm conversion with less negative inotropic effect than other agents 4, 5, 6
Amiodarone dosing: 5-7 mg/kg IV over 30-60 minutes, then 1.2-1.8 g/day continuous infusion, as recommended by the American College of Cardiology 4, 6

The American College of Cardiology states that all patients require antithrombotic therapy regardless of the management approach chosen 1, 2, 3
For AF duration >48 hours or unknown: anticoagulate for 3-4 weeks before and after cardioversion (target INR 2-3), as recommended by the American College of Cardiology 1, 2, 3
In hemodynamically unstable patients requiring immediate cardioversion, initiate heparin concurrently and continue oral anticoagulation for 3-4 weeks post-cardioversion, according to the American College of Cardiology 1, 2

The American College of Cardiology recommends immediate electrical cardioversion if Wolff-Parkinson-White syndrome is suspected and the patient is hemodynamically unstable 5, 3
If stable enough for pharmacological management: use IV procainamide or ibutilide, never AV nodal blocking agents (beta-blockers, calcium channel blockers, digoxin), as recommended by the American College of Cardiology 1, 5